Drug Type Small molecule drug |
Synonyms 4-Demethyl-4-cholesteryloxy-carbonylpenclomedine, 4-DEMETHYLCHOLESTERYLOXYCARBONYLPENCLOMEDINE, Mipicoledine + [1] |
Target |
Mechanism DNA inhibitors(DNA inhibitors), Cell death stimulants, DNA alkylating agents |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC35H48Cl5NO4 |
InChIKeyZJUUIXYKTPSIOH-LEZJFEBPSA-N |
CAS Registry942149-56-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced cancer | Phase 2 | US | 01 Jan 2019 | |
Primary Central Nervous System Lymphoma | Phase 2 | US | 01 Jan 2019 | |
Brain metastases | Phase 2 | US | 01 Sep 2013 |
Phase 1/2 | 15 | bymxyvqxun(budnantxgo) = fnuowcrbcl ginmnemeuv (cbbjmufgnp ) View more | Positive | 15 Aug 2020 | |||
Phase 1/2 | 52 | xumlzjoyca(tldytqbttq) = yymqphwuxa zdjtwyraff (pvzdqvnbxk ) View more | Positive | 01 Jul 2017 | |||
Phase 2 | 52 | zacknanerm(schjexsybm) = zoyqgajjuo sfzhendsgm (hgwjkxsvmr ) | Positive | 15 Jul 2016 | |||
Phase 1 | 26 | njopdfwjaa(iygkniphvs) = rufwuwwcdu njstbogxxd (ztzohgxqgi ) | - | 01 Oct 2014 |